This is part of the Spotlight on Glaucoma series in which glaucoma experts provide their perspective on some of the important questions in glaucoma management. In this segment, Peter Netland advises switching medications both when monotherapy does not meet expectations and when the patient is not at target IOP, stressing the need for decisions to be evidence-based and individualized for the patient.